Gonoshasthaya Kendra seeks permission to produce corona testing kit
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
SUNDAY, MAY 29, 2022
SUNDAY, MAY 29, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Gonoshasthaya Kendra seeks permission to produce corona testing kit

Health

TBS Report
18 March, 2020, 12:35 am
Last modified: 18 March, 2020, 12:46 am

Related News

  • Indonesia to drop outdoor mask mandate as Covid-19 infections drop
  • WHO: Covid-19 falling everywhere, except Americas and Africa
  • N Korea reports first Covid-19 outbreak, orders lockdown
  • 34 volunteers chose to get covid. Here’s what scientists learned
  • Setback for Shanghai's Covid battle; Beijing focus on mass testing

Gonoshasthaya Kendra seeks permission to produce corona testing kit

Gonoshasthaya hopes to supply the kit at Tk200 to vendors or labs

TBS Report
18 March, 2020, 12:35 am
Last modified: 18 March, 2020, 12:46 am
File photo - Test kits have been one of the main ways to determine if a patient has coronavirus/Collected
File photo - Test kits have been one of the main ways to determine if a patient has coronavirus/Collected

Gonoshasthaya Kendra in a press release on Tuesday said it was going to develop a point-of-care kit to detect coronavirus in collaboration with RNA Biotech Limited, a laboratory in Dhaka. 

Point-of-care testing is a simple medical test performed close to the patient where the results are available faster than samples sent to a laboratory. 

"We applied for the Directorate General of Drug Administration approval. With its permission, we will be ready for production in a month," the press release read.
 
Gonoshasthaya hopes to supply the kit at Tk200 to vendors or labs. 

It also said the government should take regulatory measures so that the common people can do the test within a cost of Tk300.
 

Bangladesh / Top News

Gonoshasthaya Kendra / Coronavirus

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Central bankers’ refusal to embark into ‘hard helicopter money’ experiment have been a good idea. Photo: Reuters
    Interbank exchange rate for dollar set at Tk89
  • A Regio regional passenger train operated by Deutsche Bahn AG travels on a bridge in Berlin. Photographer: Krisztian Bocsi/Bloomberg
    Why Germany is offering a summer of cheap trains
  • Patients opting to delay crucial treatment amid rising costs
    Patients opting to delay crucial treatment amid rising costs

MOST VIEWED

  • 40 new cases reported in 24hrs
    40 new cases reported in 24hrs
  • Patients opting to delay crucial treatment amid rising costs
    Patients opting to delay crucial treatment amid rising costs
  • Photo: TBS
    After 72-hour ultimatum, health directorate goes after illegal medical facilities 
  • 28 new Covid cases reported in a day
    28 new Covid cases reported in a day
  • Photo: TBS
    28 unlicensed hospitals, clinics closed in 5 districts
  • DGHS. Photo: Zia Chowdhury/TBS
    DGHS to conduct drives against unregistered pvt hospitals, clinics from Sunday 

Related News

  • Indonesia to drop outdoor mask mandate as Covid-19 infections drop
  • WHO: Covid-19 falling everywhere, except Americas and Africa
  • N Korea reports first Covid-19 outbreak, orders lockdown
  • 34 volunteers chose to get covid. Here’s what scientists learned
  • Setback for Shanghai's Covid battle; Beijing focus on mass testing

Features

Central bankers’ refusal to embark into ‘hard helicopter money’ experiment have been a good idea. Photo: Reuters

Venice has a 400-year-old Covid monetary lesson

1h | Panorama
Aiman R Khan. Illustration: TBS

Why ‘marry your rapist’ court orders are not always what they seem

4h | Thoughts
Photo: Collected

Top 3 The Ordinary products that give extraordinary results

6h | Mode
Photo: Courtesy

KVN Beauty: Channel your inner Bangalee baddie

6h | Mode

More Videos from TBS

Paper industry worth thousands of crores in Bogura

Paper industry worth thousands of crores in Bogura

1h | Videos
Photo: TBS

Tips to help you become a successful lawyer

7h | Videos
Photo: TBS

Harassment over 'indecent clothing': Women gather at Narsingdi railway station to protest, show solidarity

7h | Videos
People bid adieu to Abdul Gaffar Chowdhury

People bid adieu to Abdul Gaffar Chowdhury

7h | Videos

Most Read

1
Bangladesh Bank GM, DGM’s designation changed
Banking

Bangladesh Bank GM, DGM’s designation changed

2
Corporates go cashless…tax cut on cards
NBR

Corporates go cashless…tax cut on cards

3
Photo: Courtesy
Panorama

Misfit Technologies: A Singaporean startup rooted firmly in Bangladesh

4
British International Investment (BII) CEO Nick O’Donohoe. Illustration: TBS
Economy

BII to invest $450m in Bangladesh in 5 years

5
Representational image. Picture: Pixabay
Economy

Govt raises regulatory duty to discourage imports of 130 products

6
Photo: Collected
Industry

Spanish recycled cotton producer opens new facility in Bangladesh

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab